Relx (RLXXF) Financials

$36.87 +0.37 (+1.01%)

As of 02:44 PM Eastern

Annual Income Statements for Relx

This table shows Relx's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	1,486	1,429	2,237	1,819	1,957	1,650	1,958	1,971	2,230	2,388	2,751
Consolidated Net Income / (Loss)	1,494	1,429	2,237	1,819	2,000	1,650	1,986	1,971	2,278	2,434	2,794
Net Income / (Loss) Continuing Operations	1,494	1,429	2,237	1,819	1,957	1,650	1,958	1,971	2,230	2,388	2,751
Total Pre-Tax Income	1,934	1,800	2,325	2,191	2,447	2,025	2,426	2,552	2,925	3,202	3,698
Total Operating Income	2,206	2,107	2,573	2,502	2,730	2,062	2,504	2,783	3,359	3,528	4,011
Total Gross Profit	5,662	5,430	6,367	6,176	6,783	6,314	6,321	6,652	7,576	7,680	8,548
Total Revenue	8,800	8,500	9,917	9,545	10,434	9,710	9,779	10,329	11,674	11,812	12,896
Total Cost of Revenue	4,560	3,070	3,550	3,368	3,651	3,397	3,459	3,677	4,098	4,132	4,347
Operating Cost of Revenue	4,560	3,070	3,550	3,368	3,651	3,397	3,459	3,677	4,098	4,132	4,347
Total Operating Expenses	2,034	3,323	3,793	3,674	4,053	4,251	3,816	3,869	4,217	4,152	4,537
Selling, General & Admin Expense	2,128	3,368	3,843	3,715	4,053	4,251	3,816	3,869	4,217	4,152	4,537
Total Other Income / (Expense), net	-273	-295	-240	-303	-325	-53	-107	-249	-483	-373	-356
Interest Expense	-	263	269	269	404	235	192	243	401	373	385
Other Income / (Expense), net	-273	-32	28	-34	80	182	85	-6.04	-82	0.00	28
Income Tax Expense	439	371	88	372	448	376	440	581	646	768	904
Basic Earnings per Share	-	$0.56	$1.10	$0.72	$0.77	$0.64	$0.76	$1.03	$1.20	$1.30	$1.51
Weighted Average Basic Shares Outstanding	-	-	2.16B	1.96B	1.93B	1.93B	1.93B	1.91B	1.88B	1.86B	1.82B
Diluted Earnings per Share	-	$0.55	$1.09	$0.71	$0.77	$0.63	$0.76	$1.02	$1.19	$1.29	$1.51
Weighted Average Diluted Shares Outstanding	-	-	2.16B	1.96B	1.93B	1.93B	1.93B	1.91B	1.88B	1.86B	1.82B
Weighted Average Basic & Diluted Shares Outstanding	-	-	2.16B	1.96B	1.93B	1.93B	1.93B	1.91B	1.88B	1.86B	1.82B

No quarterly income statements for Relx are available.

This table details how cash moves in and out of Relx's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	699	11	-61	1.27	36	475	85	1,245	1,268	1,596	2,590
Net Cash From Operating Activities	2,074	-2,148	2,586	2,529	2,768	2,180	2,722	2,900	3,131	3,265	3,814
Net Cash From Continuing Operating Activities	2,074	2,148	2,586	2,529	852	2,180	2,722	2,900	3,131	3,265	3,814
Net Income / (Loss) Continuing Operations	2,774	2,851	3,412	3,255	0.00	3,092	3,343	3,697	4,294	4,409	5,022
Consolidated Net Income / (Loss)	2,774	-2,851	3,412	3,255	-	3,092	3,343	3,697	4,294	4,409	5,022
Non-Cash Adjustments To Reconcile Net Income	-505	-496	-607	-726	232	-677	-462	-598	-789	-829	-858
Changes in Operating Assets and Liabilities, net	-195	-232	-220	-	620	-235	-159	-199	-375	-314	-351
Net Cash From Investing Activities	-622	-814	-561	-1,619	971	-1,602	-518	-1,037	-725	-720	-1,035
Net Cash From Continuing Investing Activities	-265	-814	-561	-1,619	187	-1,240	-425	-617	-209	-278	-452
Purchase of Property, Plant & Equipment	-96	-63	1.35	-71	62	-59	-38	-43	-38	-25	-28
Acquisitions	-281	-474	-	-1,191	508	-1,187	-343	-476	-158	-213	-350
Purchase of Investments	-24	-7.40	113	-17	11	-2.73	-11	-80	-10	-5.01	-56
Sale of Property, Plant & Equipment	1.47	-1.23	-69	5.10	2.65	0.00	6.75	0.00	8.92	0.00	0.00
Divestitures	-60	-	-235	6.37	-	-34	-41	-18	-11	-35	-17
Net Cash From Financing Activities	-1,656	-1,323	-2,086	-908	1,761	-647	-2,168	-1,611	-2,621	-2,586	-2,758
Net Cash From Continuing Financing Activities	-1,110	-1,323	-2,086	-908	3,990	-464	-2,211	-1,037	-1,654	-1,391	-772
Repayment of Debt	-274	-352	-1,082	-390	1,083	-2,279	-852	-164	-972	-696	-523
Payment of Dividends	-871	-854	-1,043	-1,024	1,128	-1,210	-1,256	-1,198	-1,358	-1,415	-1,608
Issuance of Debt	737	744	979	1,408	966	3,198	0.00	479	830	890	1,513
Issuance of Common Equity	35	28	43	27	38	-51	-1.35	-60	-64	-94	-102
Other Financing Activities, net	-	9.87	15	18	29	-123	-103	-94	-89	-76	-51

No quarterly cash flow statements for Relx are available.

This table presents Relx's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	16,921	17,064	17,834	18,272	19,318	18,708	19,117	19,009	18,948	19,844
Total Current Assets	2,969	2,985	2,995	3,240	3,106	3,182	3,706	3,662	3,751	3,980
Cash & Equivalents	200	150	145	183	120	153	403	198	149	176
Short-Term Investments	25	39	13	30	26	42	25	43	44	67
Accounts Receivable	2,486	2,530	2,567	2,739	-	2,646	2,905	2,960	3,144	3,319
Inventories, net	258	266	270	288	328	342	373	461	414	418
Plant, Property, & Equipment, net	275	262	252	239	221	177	152	126	103	97
Plant, Property & Equipment, gross	275	262	252	239	221	177	152	126	103	97
Total Noncurrent Assets	13,677	13,817	14,587	14,752	15,991	14,899	14,884	14,829	14,757	15,436
Long-Term Investments	295	328	132	333	141	144	153	124	115	176
Goodwill	7,887	8,058	8,789	9,042	9,866	9,944	10,130	10,224	10,287	10,663
Intangible Assets	4,447	4,315	4,502	4,574	4,678	4,460	4,256	4,126	3,962	4,131
Employee Benefit Assets	0.00	30	-	60	-	62	156	152	233	265
Other Noncurrent Operating Assets	470	504	583	427	901	288	188	204	160	200
Total Liabilities & Shareholders' Equity	16,921	17,064	17,834	18,272	12,013	17,879	18,386	18,379	18,353	19,291
Total Liabilities	14,073	13,940	14,829	15,370	16,449	14,356	14,583	14,626	14,561	16,630
Total Current Liabilities	6,616	6,301	6,779	7,880	5,974	4,747	6,264	6,978	5,392	5,957
Accounts Payable	4,293	4,455	4,372	4,610	4,452	4,421	4,851	5,060	5,161	5,739
Current Deferred & Payable Income Tax Liabilities	755	756	573	493	203	259	301	208	149	206
Other Current Liabilities	126	59	60	48	161	66	62	37	81	12
Total Noncurrent Liabilities	7,451	7,639	8,045	7,489	10,475	9,296	8,319	7,631	7,401	8,560
Long-Term Debt	5,043	6,067	6,336	5,769	-	8,325	8,128	8,279	8,194	9,772
Noncurrent Employee Benefit Liabilities	785	473	559	749	916	425	222	232	207	207
Other Noncurrent Operating Liabilities	221	103	93	186	79	30	289	181	174	141
Total Equity & Noncontrolling Interests	2,848	3,125	3,005	2,902	391	4,352	4,534	4,382	4,387	3,214
Total Preferred & Common Equity	2,801	3,096	2,967	2,870	5,289	4,363	4,560	4,409	4,359	3,182
Total Common Equity	2,801	3,096	1,164	2,870	2,867	4,363	4,560	4,409	4,359	3,182
Common Stock	279	303	369	379	391	386	337	350	341	355
Treasury Stock	-1,815	-2,203	-935	-1,105	1,211	-1,183	-500	-705	-904	-546
Other Equity Adjustments	4,337	4,997	1,730	3,596	1,695	5,160	4,723	4,763	4,922	3,373
Noncontrolling Interest	47	28	38	32	2.73	-11	-27	-27	29	32

This table presents Relx's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q4 2023	Q4 2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Total Assets	19,117	19,009	18,948
Total Current Assets	3,706	3,662	3,751
Cash & Equivalents	403	198	149
Short-Term Investments	25	43	44
Accounts Receivable	2,905	2,960	3,144
Inventories, net	373	461	414
Plant, Property, & Equipment, net	152	126	103
Plant, Property & Equipment, gross	152	126	103
Total Noncurrent Assets	14,884	14,829	14,757
Long-Term Investments	153	124	115
Goodwill	10,130	10,224	10,287
Intangible Assets	4,256	4,126	3,962
Employee Benefit Assets	156	152	233
Other Noncurrent Operating Assets	188	204	160
Total Liabilities & Shareholders' Equity	18,386	18,379	18,353
Total Liabilities	14,583	14,626	14,561
Total Current Liabilities	6,264	6,978	7,160
Accounts Payable	4,851	5,060	5,161
Current Deferred & Payable Income Tax Liabilities	301	208	149
Other Current Liabilities	62	37	81
Total Noncurrent Liabilities	8,319	7,631	7,401
Long-Term Debt	8,128	8,279	8,194
Noncurrent Employee Benefit Liabilities	222	232	207
Other Noncurrent Operating Liabilities	289	181	174
Total Equity & Noncontrolling Interests	4,534	4,382	4,387
Total Preferred & Common Equity	4,560	4,409	4,359
Total Common Equity	4,560	4,409	4,359
Common Stock	337	350	341
Treasury Stock	-500	-705	-904
Other Equity Adjustments	4,723	4,763	4,922
Noncontrolling Interest	-27	-27	29

This table displays calculated financial ratios and metrics derived from Relx's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	-3.41%	16.67%	-3.75%	9.31%	-6.93%	0.71%	5.62%	13.02%	1.19%	9.17%
EBITDA Growth	0.00%	7.33%	25.37%	-5.15%	13.84%	-20.12%	15.39%	7.23%	18.04%	7.66%	14.48%
EBIT Growth	0.00%	7.33%	25.37%	-5.15%	13.84%	-20.12%	15.39%	7.23%	18.04%	7.66%	14.48%
NOPAT Growth	0.00%	-1.90%	48.04%	-16.11%	7.36%	-24.68%	22.03%	4.84%	21.77%	2.50%	12.99%
Net Income Growth	0.00%	-4.39%	56.57%	-18.68%	9.91%	-17.49%	20.37%	-0.75%	15.60%	6.83%	14.80%
EPS Growth	0.00%	0.00%	97.87%	-11.85%	7.70%	-17.82%	19.94%	34.95%	16.60%	8.23%	16.67%
Operating Cash Flow Growth	0.00%	-203.60%	220.37%	197.81%	9.46%	-21.26%	24.86%	6.54%	7.98%	4.30%	16.78%
Free Cash Flow Firm Growth	0.00%	0.00%	122.28%	-28.14%	79.38%	37.14%	-135.11%	345.93%	3.58%	6.73%	3.24%
Invested Capital Growth	0.00%	0.00%	10.02%	9.62%	1.67%	-10.50%	31.39%	-2.21%	0.80%	-0.03%	2.05%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	64.34%	63.88%	64.20%	64.71%	65.01%	65.02%	64.63%	64.40%	64.89%	65.02%	66.29%
EBITDA Margin	21.97%	24.42%	26.24%	25.85%	26.92%	23.11%	26.48%	26.88%	28.08%	29.87%	31.32%
Operating Margin	25.07%	24.79%	25.95%	26.21%	26.16%	21.24%	25.61%	26.94%	28.77%	29.87%	31.11%
EBIT Margin	21.97%	24.42%	26.24%	25.85%	26.92%	23.11%	26.48%	26.88%	28.08%	29.87%	31.32%
Profit (Net Income) Margin	16.98%	16.81%	22.56%	19.06%	19.16%	16.99%	20.31%	19.08%	19.52%	20.61%	21.67%
Tax Burden Percent	77.29%	79.37%	96.22%	83.02%	81.70%	81.46%	81.86%	77.24%	77.91%	76.03%	75.56%
Interest Burden Percent	100.00%	86.74%	89.36%	88.80%	87.12%	90.26%	93.69%	91.91%	89.23%	90.74%	91.54%
Effective Tax Rate	22.71%	20.63%	3.78%	16.98%	18.30%	18.54%	18.14%	22.76%	22.09%	23.97%	24.44%
Return on Invested Capital (ROIC)	0.00%	37.93%	26.74%	20.43%	20.79%	16.39%	18.31%	17.09%	20.96%	21.40%	23.94%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	29.76%	22.93%	16.79%	17.83%	16.05%	17.58%	14.90%	16.74%	18.35%	21.27%
Return on Net Nonoperating Assets (RNNOA)	0.00%	62.42%	48.18%	38.93%	46.90%	83.82%	65.43%	27.27%	30.15%	34.11%	49.58%
Return on Equity (ROE)	0.00%	100.35%	74.91%	59.36%	67.70%	100.21%	83.74%	44.36%	51.11%	55.51%	73.52%
Cash Return on Invested Capital (CROIC)	0.00%	-162.07%	17.19%	11.25%	19.14%	27.47%	-8.83%	19.33%	20.16%	21.44%	21.91%
Operating Return on Assets (OROA)	0.00%	12.26%	15.31%	14.14%	15.56%	11.94%	13.62%	14.68%	17.19%	18.59%	20.83%
Return on Assets (ROA)	0.00%	8.44%	13.16%	10.43%	11.08%	8.78%	10.44%	10.42%	11.95%	12.83%	14.41%
Return on Common Equity (ROCE)	0.00%	98.69%	73.97%	58.71%	66.90%	174.61%	127.64%	44.55%	51.41%	55.50%	72.93%
Return on Equity Simple (ROE_SIMPLE)	0.00%	51.01%	72.25%	61.31%	69.67%	31.19%	45.51%	43.22%	51.68%	55.85%	0.00%
Net Operating Profit after Tax (NOPAT)	1,705	1,673	2,476	2,077	2,230	1,680	2,050	2,149	2,617	2,683	3,031
NOPAT Margin	19.38%	19.68%	24.97%	21.76%	21.37%	17.30%	20.96%	20.81%	22.42%	22.71%	23.50%
Net Nonoperating Expense Percent (NNEP)	0.00%	8.17%	3.81%	3.63%	2.97%	0.35%	0.73%	2.19%	4.22%	3.05%	2.67%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	16.97%	20.67%	21.32%	23.34%
Cost of Revenue to Revenue	51.82%	36.12%	35.80%	35.29%	34.99%	34.98%	35.37%	35.60%	35.11%	34.98%	33.71%
SG&A Expenses to Revenue	24.18%	39.63%	38.75%	38.92%	38.85%	43.78%	39.03%	37.46%	36.12%	35.15%	35.18%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	23.11%	39.09%	38.25%	38.49%	38.85%	43.78%	39.03%	37.46%	36.12%	35.15%	35.18%
Earnings before Interest and Taxes (EBIT)	1,934	2,075	2,602	2,468	2,809	2,244	2,589	2,777	3,277	3,528	4,039
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,934	2,075	2,602	2,468	2,809	2,244	2,589	2,777	3,277	3,528	4,039
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	13.32	15.74	15.55	13.80	0.00	16.87	19.61	23.58
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	0.00	4.14	4.33	4.59	6.16	0.00	6.37	7.23	5.82
Price to Earnings (P/E)	0.00	0.00	0.00	21.73	23.08	27.02	30.76	0.00	33.35	35.79	27.27
Dividend Yield	2.76%	3.00%	2.38%	2.91%	2.35%	2.50%	2.13%	2.34%	1.78%	1.69%	2.14%
Earnings Yield	0.00%	0.00%	0.00%	4.60%	4.33%	3.70%	3.25%	0.00%	3.00%	2.79%	3.67%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	4.44	4.92	4.78	5.36	0.00	6.56	7.45	6.60
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	4.94	5.10	4.77	6.97	0.00	7.05	7.90	6.55
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	19.12	18.93	20.63	26.33	0.00	25.10	26.46	20.89
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	19.12	18.93	20.63	26.33	0.00	25.10	26.46	20.89
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	22.72	23.84	27.55	33.26	0.00	31.43	34.81	27.85
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	18.66	19.21	21.24	25.05	0.00	26.27	28.59	22.13
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	41.24	25.90	16.44	0.00	0.00	32.68	34.75	30.43
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	2.28	2.27	2.70	2.93	0.00	1.91	1.79	1.89	1.87	3.04
Long-Term Debt to Equity	0.00	1.77	1.94	2.11	1.99	0.00	1.91	1.79	1.89	1.87	3.04
Financial Leverage	0.00	2.10	2.10	2.32	2.63	5.22	3.72	1.83	1.80	1.86	2.33
Leverage Ratio	0.00	5.94	5.69	5.69	6.11	11.42	8.02	4.26	4.28	4.33	5.10
Compound Leverage Factor	0.00	5.15	5.08	5.06	5.33	10.30	7.51	3.91	3.82	3.93	4.67
Debt to Total Capital	0.00%	69.49%	69.43%	72.96%	74.55%	0.00%	65.67%	64.19%	65.39%	65.13%	75.25%
Short-Term Debt to Total Capital	0.00%	15.45%	10.07%	15.96%	23.94%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	54.03%	59.36%	57.00%	50.60%	0.00%	65.67%	64.19%	65.39%	65.13%	75.25%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	510.14%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.50%	0.28%	0.34%	0.28%	0.70%	-0.09%	-0.21%	-0.21%	0.23%	0.25%
Common Equity to Total Capital	0.00%	30.01%	30.29%	26.70%	25.17%	733.92%	34.42%	36.02%	34.82%	34.64%	24.50%
Debt to EBITDA	0.00	3.12	2.73	3.29	3.03	0.00	3.22	2.93	2.53	2.32	2.42
Net Debt to EBITDA	0.00	2.87	2.53	3.09	2.83	0.00	3.08	2.72	2.41	2.23	2.32
Long-Term Debt to EBITDA	0.00	2.43	2.33	2.57	2.05	0.00	3.22	2.93	2.53	2.32	2.42
Debt to NOPAT	0.00	3.88	2.87	3.90	3.81	0.00	4.06	3.78	3.16	3.05	3.22
Net Debt to NOPAT	0.00	3.57	2.66	3.67	3.57	0.00	3.90	3.51	3.02	2.94	3.09
Long-Term Debt to NOPAT	0.00	3.01	2.45	3.05	2.59	0.00	4.06	3.78	3.16	3.05	3.22
Altman Z-Score	0.00	0.00	0.00	2.34	2.54	2.33	3.40	0.00	4.02	4.54	3.91
Noncontrolling Interest Sharing Ratio	0.00%	1.65%	1.26%	1.09%	1.19%	-74.24%	-52.43%	-0.42%	-0.60%	0.02%	0.80%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	0.45	0.47	0.44	0.41	0.52	0.67	0.59	0.52	0.52	0.67
Quick Ratio	0.00	0.41	0.43	0.40	0.37	0.02	0.60	0.53	0.46	0.47	0.60
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-7,147	1,592	1,144	2,053	2,815	-988	2,430	2,517	2,687	2,774
Operating Cash Flow to CapEx	2,198.44%	-3,348.08%	3,828.00%	3,817.31%	0.00%	3,711.63%	8,765.22%	6,669.44%	10,682.61%	13,040.00%	13,504.76%
Free Cash Flow to Firm to Interest Expense	0.00	-27.19	5.92	4.26	5.08	11.98	-5.16	10.01	6.27	7.20	7.21
Operating Cash Flow to Interest Expense	0.00	-8.17	9.62	9.41	6.85	9.28	14.20	11.95	7.80	8.75	9.92
Operating Cash Flow Less CapEx to Interest Expense	0.00	-8.42	9.37	9.16	7.01	9.03	14.04	11.77	7.73	8.68	9.84
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.50	0.58	0.55	0.58	0.52	0.51	0.55	0.61	0.62	0.66
Accounts Receivable Turnover	0.00	3.42	3.95	3.75	3.93	0.00	0.00	3.72	3.98	3.87	3.99
Inventory Turnover	0.00	11.90	13.55	12.56	13.09	11.04	10.34	10.29	9.82	9.44	10.44
Fixed Asset Turnover	0.00	30.89	36.92	37.12	42.52	42.24	49.13	62.79	83.89	103.24	129.29
Accounts Payable Turnover	0.00	0.72	0.81	0.76	0.81	0.75	0.78	0.79	0.83	0.81	0.80
Days Sales Outstanding (DSO)	0.00	106.76	92.32	97.46	92.81	0.00	0.00	98.07	91.68	94.31	91.46
Days Inventory Outstanding (DIO)	0.00	30.66	26.94	29.05	27.88	33.06	35.32	35.47	37.16	38.68	34.95
Days Payable Outstanding (DPO)	0.00	510.38	449.69	478.28	449.04	486.92	468.21	460.17	441.39	451.46	457.58
Cash Conversion Cycle (CCC)	0.00	-372.96	-330.44	-351.76	-328.35	-453.86	-432.90	-326.63	-312.54	-318.47	-331.17
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	8,820	9,703	10,636	10,814	9,679	12,717	12,436	12,535	12,531	12,788
Invested Capital Turnover	0.00	1.93	1.07	0.94	0.97	0.95	0.87	0.82	0.94	0.94	1.02
Increase / (Decrease) in Invested Capital	0.00	8,820	884	933	178	-1,135	3,038	-281	100	-4.27	257
Enterprise Value (EV)	0.00	0.00	0.00	47,192	53,165	46,286	68,182	0.00	82,261	93,374	84,402
Market Capitalization	0.00	0.00	0.00	39,527	45,180	44,577	60,206	0.00	74,373	85,459	75,017
Book Value per Share	$0.00	$0.00	$1.43	$1.37	$1.46	$1.48	$2.27	$2.39	$2.31	$2.32	$1.71
Tangible Book Value per Share	$0.00	$0.00	($4.29)	($4.77)	($5.48)	($6.04)	($5.21)	($5.15)	($5.21)	($5.26)	($6.26)
Total Capital	0.00	9,333	10,221	11,114	11,401	391	12,678	12,662	12,661	12,581	12,986
Total Debt	0.00	6,485	7,096	8,109	8,499	0.00	8,325	8,128	8,279	8,194	9,772
Total Long-Term Debt	0.00	5,043	6,067	6,336	5,769	0.00	8,325	8,128	8,279	8,194	9,772
Net Debt	0.00	5,966	6,579	7,626	7,953	-287	7,987	7,546	7,915	7,886	9,352
Capital Expenditures (CapEx)	94	64	68	66	-65	59	31	43	29	25	28
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-2,429	-2,475	-2,168	-2,124	-3,014	-1,759	-2,987	-3,557	-3,601	-2,220
Debt-free Net Working Capital (DFNWC)	0.00	-2,205	-2,286	-2,010	-1,911	-2,868	-1,565	-2,558	-3,316	-3,408	-1,977
Net Working Capital (NWC)	0.00	-3,647	-3,315	-3,784	-4,640	-2,868	-1,565	-2,558	-3,316	-3,408	-1,977
Net Nonoperating Expense (NNE)	211	244	239	258	231	30	64	178	339	248	237
Net Nonoperating Obligations (NNO)	0.00	5,972	6,579	7,631	7,912	9,288	8,365	7,902	8,153	8,144	9,574
Total Depreciation and Amortization (D&A)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-28.58%	-24.96%	-22.72%	-20.36%	-31.04%	-17.99%	-28.91%	-30.47%	-30.49%	-17.22%
Debt-free Net Working Capital to Revenue	0.00%	-25.94%	-23.05%	-21.06%	-18.31%	-29.54%	-16.00%	-24.76%	-28.40%	-28.85%	-15.33%
Net Working Capital to Revenue	0.00%	-42.91%	-33.43%	-39.64%	-44.48%	-29.54%	-16.00%	-24.76%	-28.40%	-28.85%	-15.33%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	$0.72	$0.77	$0.64	$0.00	$0.85	$0.94	$1.30	$1.51
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	2.16B	1.96B	1.93B	1.93B	0.00	1.91B	1.88B	1.86B	1.82B
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.71	$0.77	$0.63	$0.00	$0.85	$0.94	$1.29	$1.51
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	2.16B	1.96B	1.93B	1.93B	0.00	1.91B	1.88B	1.86B	1.82B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	2.16B	1.96B	1.93B	1.93B	0.00	1.91B	1.88B	1.86B	1.82B
Normalized Net Operating Profit after Tax (NOPAT)	1,705	1,636	2,428	2,043	2,230	1,680	2,050	2,149	2,617	2,683	3,031
Normalized NOPAT Margin	19.38%	19.25%	24.49%	21.41%	21.37%	17.30%	20.96%	20.81%	22.42%	22.71%	23.50%
Pre Tax Income Margin	21.97%	21.18%	23.44%	22.96%	23.46%	20.86%	24.81%	24.70%	25.05%	27.10%	28.68%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	7.90	9.68	9.18	6.95	9.55	13.51	11.44	8.17	9.46	10.50
NOPAT to Interest Expense	0.00	6.36	9.21	7.73	5.52	7.15	10.69	8.85	6.52	7.19	7.88
EBIT Less CapEx to Interest Expense	0.00	7.65	9.43	8.93	7.11	9.30	13.35	11.26	8.09	9.39	10.43
NOPAT Less CapEx to Interest Expense	0.00	6.12	8.96	7.48	5.68	6.90	10.53	8.67	6.45	7.12	7.81
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	58.28%	59.76%	46.62%	56.30%	-56.40%	73.34%	63.22%	60.78%	59.62%	58.13%	57.56%
Augmented Payout Ratio	107.59%	122.71%	91.24%	108.33%	-93.70%	73.34%	63.22%	60.78%	59.62%	58.13%	57.56%

No quarterly metrics and ratios for Relx are available.

Financials Breakdown Chart

Key Financial Trends

Relx (NYSE: RELX) shows modest year-over-year shifts on its balance sheet through FY2022–FY2024. Here are the key trends drawn from the Q4 balances, focusing on potential implications for investors.

Long-Term Debt declined slightly from $8,279,127,100 (2023) to $8,193,742,400 (2024), a reduction of about $85.4 million, indicating a modest deleveraging.
Inventories, net decreased from $461,296,600 (2023) to $414,445,100 (2024), freeing up working capital.
Total Liabilities reduced from $14,626,415,400 (2023) to $14,560,670,900 (2024), lowering leverage modestly.
Accounts Receivable increased to $3,144,023,100 in 2024 from $2,960,198,900 in 2023, which could reflect higher sales activity or extended credit terms.
Goodwill increased to $10,287,253,600 in 2024 from $10,223,708,900 in 2023, contributing to a higher intangible asset base.
Total Assets edged down from $19,008,733,100 (2023) to $18,948,029,300 (2024), a slight overall contraction.
Net PPE declined from $126,155,700 (2023) to $102,672,200 (2024), suggesting depreciation or asset reductions.
Intangible Assets decreased from $4,126,183,400 (2023) to $3,961,644,400 (2024), shifting the mix of non-physical assets.
Cash & Equivalents declined from $197,516,500 (2023) to $148,999,900 (2024), reducing near-term liquidity.
Equity declined from $4,533,705,800 (2023) to $4,382,317,700 (2024), a drop of about $151.4 million, which can affect shareholder value metrics.
Current liquidity remains tight with a current ratio around 0.52x in 2024 (Current Assets $3.751B vs. Current Liabilities $7.160B), indicating ongoing liquidity concerns.

05/05/26 07:14 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Relx's Financials

When does Relx's financial year end?

According to the most recent income statement we have on file, Relx's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

How has Relx's net income changed over the last 10 years?

Relx's net income appears to be on an upward trend, with a most recent value of $2.79 billion in 2025, rising from $1.49 billion in 2015. The previous period was $2.43 billion in 2024.

What is Relx's operating income?

Relx's total operating income in 2025 was $4.01 billion, based on the following breakdown:

Total Gross Profit: $8.55 billion
Total Operating Expenses: $4.54 billion

How has Relx's revenue changed over the last 10 years?

Over the last 10 years, Relx's total revenue changed from $8.80 billion in 2015 to $12.90 billion in 2025, a change of 46.5%.

How much debt does Relx have?

Relx's total liabilities were at $16.63 billion at the end of 2025, a 14.2% increase from 2024, and a 18.2% increase since 2016.

How much cash does Relx have?

In the past 9 years, Relx's cash and equivalents has ranged from $120.18 million in 2020 to $403.37 million in 2022, and is currently $176.16 million as of their latest financial filing in 2025.

How has Relx's book value per share changed over the last 10 years?

Over the last 10 years, Relx's book value per share changed from 0.00 in 2015 to 1.71 in 2025, a change of 171.4%.

Financial statements for OTCMKTS:RLXXF last updated on 2/22/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Relx (RLXXF) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Relx's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Relx (RLXXF) Financials

Annual Income Statements for Relx

Quarterly Income Statements for Relx

Annual Cash Flow Statements for Relx

Quarterly Cash Flow Statements for Relx

Annual Balance Sheets for Relx

Quarterly Balance Sheets for Relx

Annual Metrics And Ratios for Relx

Quarterly Metrics And Ratios for Relx

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Relx's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools